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Summary
Neutrophil migration is vital for immunity and precedes effector functions such as pathogen killing. Here, we report that this process is
regulated by the Rab27a GTPase, a protein known to control granule exocytosis. Rab27a-deficient (Rab27a KO) neutrophils exhibit
migration defects in vitro and in vivo, and live-cell microscopy suggests that delayed uropod detachment causes the migratory defect.
Surface expression of CD11b, a key adhesion molecule, is increased in chemokine-stimulated Rab27a KO neutrophils compared with
the control, suggesting a turnover delay caused by a defect in elastase secretion from azurophilic granules at the rear of bone marrow
polymorphonuclear leukocytes (BM-PMNs). We suggest that Rab27a-dependent protease secretion regulates neutrophil migration
through proteolysis-dependent de-adhesion of uropods, a mechanism that could be conserved in cell migration and invasion.
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Introduction
The small GTPase Rab27a regulates transport and exocytosis of
secretory organelles in a variety of cell types e.g. melanosomes in
melanocytes and lytic granules in cytotoxic T lymphocytes
(CTLs) (Izumi, 2007; Tolmachova et al., 2004). Consistent with
this, loss of Rab27a [in Griscelli syndrome type 2 (GS-2) patients
and the ashen mutant mouse] results in partial albinism and
immune dysfunction due to defects in pigment transport and lytic
granule exocytosis in CTLs. Organism-wide expression studies
highlight the abundance of Rab27a in cells of haematopoietic
lineage e.g. mast cells, B cells, dendritic cells, eosinophils and
neutrophils (Fukuda, 2008).
Neutrophils are a vital element of the innate immunity against
bacterial infection (Nathan, 2006). Under homeostatic conditions
neutrophils are abundant in the blood (35% of circulating
leukocytes) but upon infection they rapidly extravasate and
migrate through tissue to the infection site in response to a
gradient of chemoattractants. Migrating neutrophils exhibit a
polarised phenotype, and whereas integrin-mediated adhesion at
the leading edge is crucial for migration, detachment through de-
adhesion of the uropod is necessary for the cell to move
forwards. The molecular mechanisms regulating this de-adhesion
process are poorly understood, although there is evidence that it
might involve ROCK (Alblas et al., 2001). Several studies
indicate that Rab27a regulates the secretion of azurophilic
granules at high chemoattractant concentrations; however, the
role of Rab27a-mediated azurophilic granule exocytosis in cell
migration has not been investigated (Brzezinska et al., 2008;
Munafó et al., 2007).
Results and Discussion
To investigate the impact of Rab27a deficiency on neutrophil
recruitment in vivo, the ELR-motif-containing CXC chemokine
macrophage inflammatory protein (MIP)-2 was administered
intranasally, and neutrophil recruitment into the bronchoalveolar
fluid (BALF) was monitored in Rab27a-deficient ashen mice
(Rab27a KO) and age and sex-matched C57BL/6 control (WT)
mice. As expected, MIP-2 treatment led to a significantly greater
number of Ly6G-positive neutrophils in the BALF as compared
with vehicle (PBS)-treated mice of both genotypes (WT 0.2660.1
versus 29.4364.56104 cells, Rab27a KO 2.2661.36 versus
16.9963.926104 cells) (Fig. 1B). However, the effect of MIP-2
was significantly reduced in Rab27a KO compared with WT, both
in terms of the number of BAL neutrophils (WT, 29.4364.56104
cells versus Rab27a KO, 16.9963.926104 cells) (Fig. 1B) and the
proportion of BAL neutrophils (WT, 76.4364.09% versus Rab27a
KO, 61.1064.61%) (Fig. 1A). This suggests that Rab27a regulates
chemokine-driven neutrophil migration. To test this directly we
purified bone marrow polymorphonuclear leukocytes (henceforth
BM-PMNs) of Rab27a KO and WT mice and tested their ability to
migrate in vitro. Consistent with in vivo data (Fig. 1A,B) we
observed a significant decrease in migrated Rab27a KO versus
WT BM-PMNs in response to both the chemokine MIP-2
and the classical chemoattractant LTB4, over a range of
concentrations (Fig. 1C,D). Similar results were observed in
assays measuring chemoattractant-driven N-formyl-methionine-
leucine-phenylalanine (fMLP) migration of Rab27a-knockdown
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(achieved by using small interfering RNAs) versus control DMSO-
differentiated HL-60 human neutrophils (Fig. 1E; supplementary
material Fig. S1).
To understand the basis of the Rab27a KO migration defect we
used video microscopy and cell tracking to record and compare
the movement of WT and Rab27a KO BM-PMNs migrating
towards a MIP-2 source in a Zigmond chamber (Fig. 2). We
observed that both migration distance and velocity were
significantly reduced in Rab27a KO compared with WT BM-
PMNs (Fig. 2A–C). Analysis of the directionality of movement
confirmed that migration both parallel to (shown on the x-axis,
representing chemotaxis) and perpendicular to (shown on the y-
axis, representing random migration and chemokinesis) the
chemokine gradient was reduced in Rab27a KO versus WT
BM-PMNs (Fig. 2D). However, the overall low level of random
migration meant that it was only possible to confirm that
chemotaxis towards chemokine was significantly impaired in the
mutant compared with that in the control cells (Fig. 2D).
Interestingly, a similar phenotype has been reported in a study
that examined chemotaxis using neutrophils isolated from GS
patients (Kurugöl et al., 2001). Close inspection of cell
morphology during migration revealed that both WT and
Rab27a KO BM-PMNs polarised successfully and made
membrane protrusions at the front of the cell (Fig. 2F,G).
However, we observed a striking delay in uropod release in
migrating Rab27a KO compared with WT BM-PMNs (Fig. 2E–
G; supplementary material Movies 1–4). In addition, inhibition of
uropod release in Rab27a KO BM-PMNs was often accompanied
by a loss of polarity and migration arrest (supplementary material
Movies 3,4), which might explain the observed defects in
directionality. These observations suggested that Rab27a KO
BM-PMNs initially responded normally to chemoattractant by
polarising towards its source but that their subsequent movement
was then retarded owing to delayed uropod release. Consistent
with this, flow cytometry analysis revealed that surface levels of
the MIP-2 specific receptor (CXCR2) and chemoattractant
triggered F-actin polymerisation, a hallmark of the neutrophil
response to chemoattractant, were similar in Rab27a KO and WT
BM-PMNs (supplementary material Fig. S2a–d).
Serine proteases (elastase, proteinase 3 and cathepsin G)
modulate PMN chemotaxis and inflammation (Kessenbrock et al.,
2008; Lee and Downey, 2001). It is generally considered that
they promote migration by cleaving the extracellular domain of
adhesion molecules, thereby allowing dynamic cycles of PMN
attachment and detachment in migrating cells (Pham, 2006). A
recent study has shown that inhibition of serine-protease-
dependent CD11b cleavage results in a uropod elongation and
detachment phenotype resembling that of Rab27a KO BM-PMNs
(Fig. 2E,F) (Zen et al., 2011). That study also reported that
the elastase accumulated at the uropod of migrating PMNs,
suggesting a model of protease release at the rear of the cell
allowing localised cleavage of the extracellular domain of CD11b
leading to uropod detachment and net forwards migration. We
therefore hypothesised that uropod release and chemotaxis
defects in Rab27a KO BM-PMNs results from an impairment
of serine protease secretion and adhesion molecule cleavage at
the rear of migrating PMNs. Consistent with this, by using
fluorescence microscopy, we observed that EGFP–Rab27a-
positive structures were enriched close to the rear of the cell in
migrating BM-PMNs derived from EGFP–Rab27a-expressing
transgenic mice (Fig. 3A–D). CD11b is transiently upregulated at
the cell surface in response to chemokine stimulation (Zen et al.,
2011). We observed that the chemokine-stimulated increase in
CD11b expression is sustained on neutrophils in Rab27a KO
Fig. 1. Rab27a promotes migration of neutrophils in vivo and in
vitro. (A) Leukocytes recruited to the bronchoalveolar space of WT and
Rab27a KO mice treated intranasally with MIP-2; cells were stained with
antibody against Ly6G and analysed by flow cytometry. Numbers
indicate Ly6G-positive cells as a percentage of the total cell number.
(B) Neutrophils recruited to the bronchalveloar space of WT mice and
Rab27a KO mice treated with MIP-2. Data represent the mean6s.e.m.
(n55–7 for each treatment and genotype of mice). Transwell migration of
WT versus Rab27a KO BM-PMN towards (C) MIP-2 or (D) LTB4
concentrations after 30 minutes, and (E) Rab27a-knockdown (siRab27)
versus non-targeting (NT) control transfected differentiated HL-60 cells
towards fMLP after 60 minutes. Data represent the mean from three
independent experiments (n53 for each treatment and genotype of mice
BM-PMN and knockdown HL-60 cells). *P#0.05, ***P#0.001
[Student’s t-test (B) and two-way ANOVA (C–E)].


















compared with WT BM-PMNs, suggesting that there is a defect
in its downregulation (Fig. 3E). To test this hypothesis more
directly we used a broad-spectrum inhibitor of serine proteases
(AEBSF) to determine whether protease activity is required for
neutrophil migration. At low doses (10 mM) AEBSF reduced
migration of Rab27a KO and WT BM-PMNs to a similar extent,
indicating that serine protease activity facilitates migration in
both cases (Fig. 3F). Strikingly at higher doses (50 mM) the
effect of AEBSF on migration was more pronounced on WT
compared with Rab27a KO BM-PMNs. Indeed at this level,
AEBSF reduced the number of migrating WT BM-PMNs to a
level similar to that observed in Rab27a KO cells (Fig. 3F).
These findings suggest that the Rab27a KO chemotaxis deficit
results from defective release of a subset of serine proteases.
Consistently, studies of disease models whose symptoms
resemble Rab27a deficiency (GS-2 and ashen) such as the
beige Chediak–Higashi syndrome (CHS) model mouse and the
‘gray collie’ canine Hermansky–Pudlak syndrome type 2 (HPS-
2) model, indicate that defects in elastase trafficking are
responsible for PMN dysfunction in these animals (Benson
et al., 2003; Zen et al., 2011). To test the hypothesis that reduced
release of elastase underlies the defective migratory phenotype of
the Rab27a KO BM-PMNs, we measured Rab27a KO and WT
BM-PMN chemotaxis in the presence of the specific elastase
inhibitor, elastatinal (Fig. 3G). Elastatinal caused a 30%
inhibition of migration of WT BM-PMNs but no effect on the
migration of Rab27a KO BM-PMNs, which is in contrast to
the effect of AEBSF in the same cells (Fig. 3F,G). These
observations support the hypothesis that migration defects in
Rab27a KO BM-PMNs result from defects in elastase secretion.
In conclusion, we found that Rab27a regulates PMN
chemotaxis in vitro and in vivo by regulating uropod
detachment. We observed that Rab27a-positive membranes
localised at the rear of migrating PMNs, suggesting that this
protein has a role in cargo delivery to sites proximal to the
uropod. Furthermore, we found that cell surface CD11b turnover
was reduced in chemokine-stimulated Rab27a KO BM-PMNs
and that Rab27a regulates the release of a subset of serine
proteases. We propose that Rab27a regulates BM-PMN migration
by stimulating elastase release from azurophilic granules at the
rear of BM-PMNs, thereby allowing localised proteolysis of the
extracellular domain of CD11b resulting in uropod detachment
and net forwards movement of the cell. In view of recent data
highlighting the role of Rab27a in T cell migration (Colvin et al.,
2010) and Rab27b in breast cancer cell invasion (Hendrix et al.,
2010), we suggest that Rab27 might play a general role in
regulating cell migration by allowing localised detachment at the
rear of migrating cells.
Materials and Methods
Mouse strains and purification of neutrophils
The ashen Rab27aash/ash (Rab27a KO) and transgenic EGFP–Rab27a mice were as
described previously (Barral et al., 2002; Tolmachova et al., 2004). Controls were
age- and sex-matched C57BL/6 animals. All animals were treated humanely in
accordance with the UK Home Office Regulations under PPL 70/7078. BM-PMNs
were purified as described previously (Wengner et al., 2008). Typical preparations
contained above 80% BM-PMNs.
Antibodies, immunoblot and flow cytometry
For immunoblot analysis, mouse monoclonal anti-Rab27a antibody (4B12)
(Barral et al., 2002), anti-calnexin antibody (Stressgen) and HRP-conjugated
secondary antibodies (DAKO) were used as described previously (Barral et al.,
2002). Cells were lysed by resuspension in 50 mM Tris-HCl pH 7.4, 16 protease
inhibitors (Roche), 2% (w/v) SDS, and passed through a 26G needle 10 times on
ice and processed for immunoblotting as previously described (Barral et al.,
2002). For flow cytometry using a FACScalibur cytometer, phycoerythrin (PE)-
conjugated anti-Ly6G (BD Biosciences), allophycocyanin (APC)-conjugated
CXCR2 (R&D Systems), Alexa-Fluor-647-conjugated anti-Cd11b (BD
Biosciences) antibodies were used at 1:100 dilution and Alexa-Fluor-647-
conjugated phalloidin (Molecular Probes) used at 1:1000 dilution. For surface
staining, 26105 BM-PMN cells were washed twice and resuspended in rat anti-
FccRII/RIII antibody (BD biosciences), then incubated with fluorophore-
conjugated antibodies for 30 minutes on ice. For F-actin staining, 36105
BM-PMN cells were fixed for 30 minutes at room temperature in 4%
paraformaldehyde (PFA) and permeabilised with 0.5% saponin for 15 minutes
prior to Alexa-Fluor-647–phalloidin staining. For Cd11b measurements, 26105
BM-PMNs were resuspended in RPMI1640 plus 1% BSA, stimulated with 1 nM
MIP-2 at 37 C̊ for indicated times and placed on ice prior to Cd11b staining.
Cell culture, transfection and differentiation
The human promyelocytic leukaemia cell line HL-60 (American Type Culture
Collection) was cultured in DMEM, 20% (v/v) fetal bovine serum and 10 units/ml
penicillin-streptomycin at 37 C̊ under 5% CO2. HL-60 cells were nucleofected
with non-targeting siRNA (Dharmacon) or two Rab27a-specific siRNA
Fig. 2. Rab27a regulates neutrophil migration by controlling uropod
release. (A) Tracks of WT and Rab27a KO BM-PMN migration measured
from stacks of images taken every 30 seconds for 30 minutes in a Zigmond
chamber with medium alone added to the left well and 10 nM MIP-2 added to
the right well. Black and red tracks indicate cells with net leftwards or
rightwards movement respectively. Migration distance (B), velocity (C) x-
and y-migration index (D) and uropod lifetime (E) of WT and Rab27a KO
BM-PMN. Data represent the mean6s.e.m. from 25 random cells per
experiment from four independent experiments (n54 for each genotype of
BM-PMNs). Still images of WT (F) and Rab27a KO (G) BM-PMN migration
over a course of 180 seconds (from supplementary material Movies 2 and 4).
Scale bars: 10 mm. *P#0.05, ***P#0.001 (Student’s t-test).


















oligonucleotides using the Amaxa nucleoporator (Lonza) as described previously
(Munafó et al., 2007). Nucleofected cells were then differentiated to mature
neutrophils by suspension in medium containing 1.3% DMSO for 72 hours.
In vivo neutrophil recruitment assay
The recruitment of neutrophils to the bronchoalveolar space was performed as
described previously (Fulton et al., 2002) with the following modifications. Mice
were briefly anaesthetised with isofluorane and 0.8 mg of recombinant murine
MIP-2 (Peprotech) or PBS was administered intranasally. 6 hours after challenge,
mice were killed and the bronchoalveolar lavage collected. Neutrophils were
identified as Ly6Ghigh cells and by their characteristic high-side-scatter profile.
Transwell chemotaxis assay
Chemotaxis in vitro was measured as described previously (Chatterjee et al., 2005;
Weller et al., 2005). BM-PMN or differentiated HL-60 cells (16105) were placed
on top wells of a chemotaxis plate with 3-mm pores (Receptor Technologies,
Adderbury, UK) and allowed to migrate towards recombinant murine MIP-2
(Peprotech), LTB4 and fMLP (Sigma-Aldrich), at concentrations as indicated, for
30 minutes (or 1 hour for HL-60). Migrated cells were collected, resuspended in
200 mL volume and counted for 30 seconds on the high setting using a
FACScalibur system (BD Biosciences).
Zigmond chamber neutrophil chemotaxis assay
BM-PMNs (16105) were resuspended in 50 mL of RPMI plus 1% BSA and plated
onto coverglass for 20 minutes at 37 C̊. Coverglass was washed and placed onto
the inverted Zigmond chamber (Neuroprobe). The left well contained medium and
the right contained 10 nM MIP-2. Brightfield images were taken every 30 seconds
for 30 minutes using a 106 objective on a widefield microscope (Zeiss Axiovert
200) with a heat-controlled stage (37 C̊). Stacks of images were analysed using
ImageJ software (NIH) with the chemotaxis plug-in (Ibidi). Uropod lifetime
measurements were derived by recording the elapsed time from uropod formation
to release or disappearance. EGFP–Rab27a localisation was quantified using
ImageJ software by measurement of cell-associated fluorescence close to cell rear
(,4 mm) and far from the cell rear (.4 mm). Fluorescence values were then
normalised for the different surface areas by expressing the results as fluorescence
units per unit of surface area (mm2).
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